Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way



Rating:

Share or cite this content

Citations should be made in the following way:
U. Costabel (Essen, Germany). Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre. Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Source: Eur Respir J 2011; 37: 465 Year: 2011 Alveolar proteinosis: epidemiology, possibilities of diagnosis Source: Eur Respir J 2004; 24: Suppl. 48, 671s Year: 2004 Clinical and paraclinical manifestations of pulmonary alveolar proteinosis in children Source: Eur Respir J 2007; 30: Suppl. 51, 402s Year: 2007 Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 1049 Year: 2012 Outpatient lobar lavage: a novel approach to managing pulmonary alveolar proteinosis Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 Diagnostic value of radiographic findings with literature review in Chinese pulmonary alveolar proteinosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006 Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Baseline characteristics of an Italian cohort of pulmonary alveolar proteinosis (PAP) patients Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Pulmonary alveolar proteinosis: report of two cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Occupational and environmental impact on the clinical course of autoimmune pulmonary alveolar proteinosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Fatal cases of pulmonary alveolar proteinosis: a nationwide surveillance in Japan Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Baseline characteristics of the Italian cohort of patients affected by pulmonary alveolar proteinosis (PAP) Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 Clinical characteristics of pulmonary alveolar microlithiasis in Japan Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004